|
Insider Trading: COLLAGENEX PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of COLLAGENEX PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of COLLAGENEX PHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of COLLAGENEX PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is CGPI.
The reporting company's CIK number is 1012270.
The total value of stock buying since 2005 is $196,198.
The total value of stock sales is $2,201,260.
The total value of stock exercises is $1,905,483.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at COLLAGENEX PHARMACEUTICALS INC (CGPI) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at COLLAGENEX PHARMACEUTICALS INC (CGPI) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for COLLAGENEX PHARMACEUTICALS INC (CGPI).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-02 | 0 | 0 | 6,667 | 81,870 | 23,334 | 145,836 |
| 2008-01 | 0 | 0 | 26,667 | 308,803 | 26,667 | 166,666 |
| 2007-11 | 5,200 | 40,355 | 0 | 0 | 0 | 0 |
| 2007-08 | 0 | 0 | 8,333 | 110,412 | 8,333 | 52,081 |
| 2007-07 | 0 | 0 | 30,000 | 383,145 | 30,000 | 318,750 |
| 2007-06 | 0 | 0 | 30,000 | 366,351 | 30,000 | 318,750 |
| 2007-05 | 200 | 2,096 | 0 | 0 | 0 | 0 |
| 2007-04 | 0 | 0 | 5,000 | 71,150 | 5,000 | 32,300 |
| 2006-11 | 0 | 0 | 16,667 | 233,337 | 46,667 | 442,503 |
| 2006-09 | 0 | 0 | 49,433 | 646,192 | 33,333 | 299,997 |
| 2006-06 | 0 | 0 | 0 | 0 | 10,000 | 128,600 |
| 2005-06 | 30,800 | 153,747 | 0 | 0 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for COLLAGENEX PHARMACEUTICALS INC (CGPI)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-02-08 | Broadbent Nancy C (CFO and Treasurer) | Option Exercise | 16,667 | 6.25 | 104,168 |
| 2008-02-04 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 6,667 | 12.28 | 81,870 |
| 2008-02-04 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 6,667 | 6.25 | 41,668 |
| 2008-01-28 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 13,334 | 11.81 | 157,518 |
| 2008-01-28 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 13,334 | 6.25 | 83,336 |
| 2008-01-22 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 6,666 | 10.88 | 72,526 |
| 2008-01-22 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 6,666 | 6.25 | 41,662 |
| 2007-11-28 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Purchase | 200 | 7.30 | 1,460 |
| 2007-11-28 | Theobald Klaus (Sr VP & Chief Medical Officer) | Purchase | 1,050 | 7.41 | 7,780 |
| 2007-11-27 | Theobald Klaus (Sr VP & Chief Medical Officer) | Purchase | 300 | 7.41 | 2,223 |
| 2007-11-20 | Ford James Gregory (VP, Business Development) | Purchase | 1,500 | 7.87 | 11,805 |
| 2007-11-20 | Theobald Klaus (Sr VP & Chief Medical Officer) | Purchase | 1,300 | 7.75 | 10,072 |
| 2007-11-16 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Purchase | 400 | 8.01 | 3,204 |
| 2007-11-08 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Purchase | 450 | 8.47 | 3,811 |
| 2007-08-09 | Broadbent Nancy C (CFO and Treasurer) | Sale | 8,333 | 13.25 | 110,412 |
| 2007-08-09 | Broadbent Nancy C (CFO and Treasurer) | Option Exercise | 8,333 | 6.25 | 52,081 |
| 2007-07-16 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.65 | 126,519 |
| 2007-07-16 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 10,000 | 10.62 | 106,250 |
| 2007-07-09 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.87 | 128,680 |
| 2007-07-09 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 10,000 | 10.62 | 106,250 |
| 2007-07-02 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.79 | 127,946 |
| 2007-07-02 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 10,000 | 10.62 | 106,250 |
| 2007-06-25 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.35 | 123,518 |
| 2007-06-25 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 10,000 | 10.62 | 106,250 |
| 2007-06-18 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.24 | 122,423 |
| 2007-06-18 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 10,000 | 10.62 | 106,250 |
| 2007-06-11 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Sale | 10,000 | 12.04 | 120,410 |
| 2007-06-11 | Pfeiffer David F (Sr. VP, Sales and Marketing) | Option Exercise | 10,000 | 10.62 | 106,250 |
| 2007-05-22 | Powell Andrew Kenneth William (VP, G. Counsel and Corp. Sec.) | Purchase | 200 | 10.48 | 2,096 |
| 2007-04-19 | Ford James Gregory (VP, Business Development) | Sale | 5,000 | 14.23 | 71,150 |
| 2007-04-19 | Ford James Gregory (VP, Business Development) | Option Exercise | 5,000 | 6.46 | 32,300 |
| 2006-11-09 | Easton Robert J | Option Exercise | 15,000 | 9.75 | 146,250 |
| 2006-11-09 | Daverman James E | Option Exercise | 15,000 | 9.75 | 146,250 |
| 2006-11-07 | Broadbent Nancy C (CFO and Treasurer) | Sale | 8,334 | 14.25 | 118,759 |
| 2006-11-07 | Broadbent Nancy C (CFO and Treasurer) | Option Exercise | 8,334 | 9.00 | 75,006 |
| 2006-11-06 | Broadbent Nancy C (CFO and Treasurer) | Sale | 8,333 | 13.75 | 114,578 |
| 2006-11-06 | Broadbent Nancy C (CFO and Treasurer) | Option Exercise | 8,333 | 9.00 | 74,997 |
| 2006-09-26 | Broadbent Nancy C (CFO and Treasurer) | Sale | 6,132 | 13.25 | 81,249 |
| 2006-09-26 | Broadbent Nancy C (CFO and Treasurer) | Option Exercise | 6,132 | 9.00 | 55,188 |
| 2006-09-25 | Broadbent Nancy C (CFO and Treasurer) | Sale | 2,201 | 13.25 | 29,163 |
| 2006-09-25 | Broadbent Nancy C (CFO and Treasurer) | Option Exercise | 2,201 | 9.00 | 19,809 |
| 2006-09-19 | Daverman James E | Sale | 13,000 | 13.06 | 169,780 |
| 2006-09-18 | Easton Robert J | Sale | 10,000 | 13.07 | 130,700 |
| 2006-09-15 | Barnett Peter R | Sale | 18,100 | 13.00 | 235,300 |
| 2006-09-15 | Barnett Peter R | Option Exercise | 25,000 | 9.00 | 225,000 |
| 2006-06-05 | Easton Robert J | Option Exercise | 10,000 | 12.86 | 128,600 |
| 2005-06-15 | Daverman James E (Director) | Purchase | 20,000 | 5.03 | 100,640 |
| 2005-06-13 | Powell Andrew Kenneth William (VP, G. Counsel and C) | Purchase | 1,800 | 4.86 | 8,757 |
| 2005-06-10 | Stewart Colin W (President and CEO) | Purchase | 5,000 | 4.95 | 24,750 |
| 2005-06-10 | Pfeiffer David F (Sr. VP, Sales and Ma) | Purchase | 4,000 | 4.90 | 19,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of COLLAGENEX PHARMACEUTICALS INC (symbol CGPI,
CIK number 1012270) see
the Securities and Exchange Commission (SEC) website.
|
|
